Mersana Therapeutics, Inc.
NASDAQ:MRSN
0.4649 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -69.192 | -171.67 | -204.212 | -170.06 | -88.045 | -28.208 | -64.257 | -38.707 | -13.7 | -16.428 |
| Depreciation & Amortization
| 1.628 | 1.517 | 0.927 | 0.855 | 1.01 | 1.245 | 1.257 | 0.928 | 0.655 | 0.297 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -0.086 | -0.222 | -0.386 | -0.134 | -0.102 | -0.349 |
| Stock Based Compensation
| 16.458 | 21.136 | 21.522 | 18.409 | 7.172 | 4.872 | 3.884 | 1.422 | 0.668 | 0.349 |
| Change In Working Capital
| -30.738 | -18.763 | 133.099 | 10.085 | 5.105 | -45.534 | 4.176 | -6.029 | 43.965 | 6.146 |
| Accounts Receivables
| 0 | 30 | -30 | 0 | 0 | 0.459 | 0.325 | 0.267 | -0.411 | 1.197 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -1.502 | 2.609 | 2.422 | 1.421 | 0.304 |
| Accounts Payables
| -2.857 | -6.08 | 0.947 | 0.483 | 0.942 | -3.11 | 7.375 | 1.335 | -0.325 | 0.926 |
| Other Working Capital
| -27.881 | -42.683 | 162.152 | 9.602 | 4.163 | -41.381 | -6.133 | -10.053 | 43.28 | 3.719 |
| Other Non Cash Items
| -0.496 | -1.102 | -0.699 | 0.723 | 0.148 | 0.103 | 0.11 | -0.159 | 0.102 | 0.349 |
| Operating Cash Flow
| -82.34 | -168.882 | -49.363 | -139.988 | -74.696 | -67.744 | -55.216 | -42.679 | 31.588 | -9.636 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.132 | -2.168 | -2.197 | -0.648 | -0.473 | -0.605 | -1.37 | -1.143 | -1.084 | -0.619 |
| Acquisitions Net
| 0 | 0 | 150.519 | 0 | 0 | 26.688 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -133.431 | -155.919 | -247.519 | 0 | 0 | -53.688 | 0 | -145.701 | 0 | -0.164 |
| Sales Maturities Of Investments
| 145 | 277.97 | 97 | 0 | 37.5 | 27 | 88.565 | 47.22 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -150.519 | 0 | 37.5 | -26.688 | 88.565 | -98.481 | 0 | -0.164 |
| Investing Cash Flow
| 11.437 | 119.883 | -152.716 | -0.648 | 37.027 | -27.293 | 87.195 | -99.624 | -1.084 | -0.783 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -2.23 | -0.262 | -0.272 | 18.341 | -0.116 | 4.878 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 5.78 | 93.539 | 150.893 | 43.087 | 227.026 | 92.162 | 1.064 | 68.145 | 58.259 | 9.96 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0.146 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.542 | 1.398 | 2.396 | 2.218 | 3.502 | 0.664 | 1.064 | 0.452 | 58.259 | 9.96 |
| Financing Cash Flow
| 4.092 | 94.675 | 153.017 | 63.646 | 230.412 | 97.704 | 1.064 | 68.597 | 58.259 | 9.96 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -66.811 | 45.676 | -49.062 | -76.99 | 192.743 | 2.667 | 33.043 | -73.706 | 88.763 | -0.459 |
| Cash At End Of Period
| 108.228 | 175.039 | 129.363 | 178.425 | 255.415 | 62.672 | 60.005 | 26.591 | 100.297 | 11.534 |